Amphix Bio Gains Breakthrough Device Designation
The designation covers use of a drug/device combination product to treat degenerative disc disease with transforaminal lumbar interbody fusion....
The designation covers use of a drug/device combination product to treat degenerative disc disease with transforaminal lumbar interbody fusion....
Results support integration of antibiotic-eluting bone substitute materials, like CERAMENT G and CERAMENT V, into treatment guidelines for orthopedic infections....
i-FACTOR is now approved for single-level ACDF with an allograft bone ring, or with a PEEK, titanium alloy or PEEK/titanium...
The trial is evaluating SB-01, the first intradiscal pharmacologic treatment to enter Phase III studies for the treatment of chronic...
NanoBone is a next-generation osteoinductive bone graft comprising nanostructured hydroxyapatite for remodelling bone....
The first patient has been treated in the Phase I/II OASIS Trial, a study evaluating the safety and effectiveness of...
COPAL G+V antibiotic-loaded PMMA bone cement contains gentamicin and vancomycin to support periprosthetic joint infection treatment....
MACI Arthro allows surgeons to evaluate and prepare the defect site as well as deliver the MACI implant through small...
B-MAN uses a centrifuge-free method for the collection of high-quality aspirate with minimal contaminants....
OssiGraft contains a high composition of cancellous bone, which may promote faster bone regeneration vs. legacy bone allografts that are...
As a guest member you get access to more articles and videos every month.
We’ll send a recovery link to your email.
Return to Homepage